Customer Center
Login | Register


Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.

Read More


Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.

Read More


Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.

Learn More


Luminex® Blog

In Indiana, Riverview Health Improves Patient Outcomes with the VERIGENE® System

Flexibility and targeted approach reduced costs and time to results

At the recent South Central Association for Clinical Microbiology (SCACM) meeting, Ronald Reitenour, MT(ASCP), Area Coordinator Microbiology from Riverview Health in Noblesville, Indiana, presented results from his team’s experience with the VERIGENE® System and the impact the entire VERIGENE® infectious disease portfolio has made on patient care…”

Continue Reading…

We Are Luminex

We Are Luminex


At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.

Watch more videos >

Luminex on Twitter

Congratulations to our partner NMI TT Pharmaservices on being awarded a research grant!
h J R
Mauricio Agueros, veteran and Austin native, keeps our Field Services department running smoothly.…
h J R
RT @SelectScience: Customized multiplex xMAP assays enable development of diagnostic tests for cancer & infectious diseases. @Luminex https…
h J R

Latest News

June 5
Luminex Corporation’s VERIGENE Gram-Positive and Gram-Negative Blood Culture Panels Receive Reimbursement Approval in Japan

May 25
Luminex Corporation To Present At Jefferies 2017 Global Healthcare Conference

May 24
Luminex Corporation Declares Second Quarter Cash Dividend

May 3
Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

May 1
Luminex Corporation Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance

April 26
Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference


APHL Annual Meeting
June 11-14
Providence, RI

Western PA CLMA Conference
June 21
Township, PA

AACC Annual Meeting & Clinical Lab Expo
July 30-August 3
San Diego, CA

SWACM Annual Meeting
September 6-9
St. Louis, MO

Intermountain States Seminar
September 29-30
Jackson, WY